Contains fulltext : 171451.pdf (publisher's version ) (Closed access)The purpose of this study was to investigate the effects on the brain of multiple sessions of blood-brain barrier (BBB) disruption using focused ultrasound (FUS) in combination with micro-bubbles over a range of acoustic exposure levels. Six weekly sessions of FUS, using acoustical pressures between 0.66 and 0.80 MPa, were performed under magnetic resonance guidance. The success and degree of BBB disruption was estimated by signal enhancement of post-contrast T1-weighted imaging of the treated area. Histopathological analysis was performed after the last treatment. The consequences of repeated BBB disruption varied from no indications of vascular damage t...
The blood-brain barrier (BBB) is a major anatomical and physiological barrier limiting the passage o...
Radioimmunotherapy using a radiolabeled monoclonal antibody that targets tumor cells has been shown ...
The blood-brain-barrier (BBB) is the single most limiting factor in the delivery of neurotherapeutic...
Focused ultrasound (FUS) is a disruptive medical technology and its implementation in the clinic inc...
[[abstract]]It has been shown that focused ultrasound (FUS) can disrupt the blood-brain barrier (BBB...
[[abstract]]The use of an ultrasound contrast agent (UCA) with focused ultrasound sonication has the...
Abstract—The use of an ultrasound contrast agent (UCA) with focused ultrasound sonication has the po...
OBJECTIVE The application of pharmacological therapeutics in neurological disorders is limited by th...
It has been shown that focused ultrasound (FUS) is capable of noninvasive and reversible disruption ...
[[abstract]]It has been shown that focused ultrasound (FUS) is capable of noninvasive and reversible...
The treatment of neuropathologies is complicated by many factors; common, however, to most afflictio...
Pulsed ultrasound combined with microbubbles use can disrupt the blood–brain barrier (BBB) temporari...
[[abstract]]Focused ultrasound combined with an intravascular ultrasound contrast agent can induce t...
It has been shown that the blood-brain barrier (BBB) can be locally disrupted by focused ultrasound ...
Focused ultrasound combined with an intravascular ultrasound contrast agent can induce transient dis...
The blood-brain barrier (BBB) is a major anatomical and physiological barrier limiting the passage o...
Radioimmunotherapy using a radiolabeled monoclonal antibody that targets tumor cells has been shown ...
The blood-brain-barrier (BBB) is the single most limiting factor in the delivery of neurotherapeutic...
Focused ultrasound (FUS) is a disruptive medical technology and its implementation in the clinic inc...
[[abstract]]It has been shown that focused ultrasound (FUS) can disrupt the blood-brain barrier (BBB...
[[abstract]]The use of an ultrasound contrast agent (UCA) with focused ultrasound sonication has the...
Abstract—The use of an ultrasound contrast agent (UCA) with focused ultrasound sonication has the po...
OBJECTIVE The application of pharmacological therapeutics in neurological disorders is limited by th...
It has been shown that focused ultrasound (FUS) is capable of noninvasive and reversible disruption ...
[[abstract]]It has been shown that focused ultrasound (FUS) is capable of noninvasive and reversible...
The treatment of neuropathologies is complicated by many factors; common, however, to most afflictio...
Pulsed ultrasound combined with microbubbles use can disrupt the blood–brain barrier (BBB) temporari...
[[abstract]]Focused ultrasound combined with an intravascular ultrasound contrast agent can induce t...
It has been shown that the blood-brain barrier (BBB) can be locally disrupted by focused ultrasound ...
Focused ultrasound combined with an intravascular ultrasound contrast agent can induce transient dis...
The blood-brain barrier (BBB) is a major anatomical and physiological barrier limiting the passage o...
Radioimmunotherapy using a radiolabeled monoclonal antibody that targets tumor cells has been shown ...
The blood-brain-barrier (BBB) is the single most limiting factor in the delivery of neurotherapeutic...